News Story
Leading cancer research
UNSW has been awarded almost seven million dollars in funding for cancer research from the NSW government. UNSW was awarded more than any other institution in the state.
Professor Philip Hogg, who is the Director of UNSW’s Cancer Research Centre, has been awarded $3.75 million for his work on anti-mitochondrial cancer drugs.
Those drugs will be tested in Australia on patients with bowel cancer in the coming years. This trial has been made possible by the new Lowy Cancer Research Centre.
Clinical trials for the earlier version of this drug have been carried out in the UK because there has not been the funding needed in Australia.
Professor Levon Khachigian, from the Centre for Vascular Research (CVR) at UNSW has been awarded $2.96 million for novel gene-targeted therapies for Basel Cell Carcinoma.
UNSW conjoint Professor Pamela Russell, who is based at the Oncology Research Centre at the Prince of Wales Hospital, was given a $240,000 infrastructure grant.
For the full story, see the UNSW website.
News story published 26/06/2007